18 min listen
Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks
FromVJHemOnc Podcast
Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks
FromVJHemOnc Podcast
ratings:
Length:
15 minutes
Released:
Jan 3, 2023
Format:
Podcast episode
Description
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,...
The post Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks appeared first on VJHemOnc.
The post Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks appeared first on VJHemOnc.
Released:
Jan 3, 2023
Format:
Podcast episode
Titles in the series (100)
MRD testing in multiple myeloma: new technology with promising clinical applications: Determining measurable residual disease (MRD) status is undoubtedly proving to be an effective method of prognostication and measurement of response... by VJHemOnc Podcast